查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970755

立體定位手術器材市場－全球產業規模、佔有率、趨勢、機會、預測：按產品類型、應用、地區和競爭格局分類，2021-2031年

Stereotactic Surgery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球立體定位手術器械市場預計將從 2025 年的 271.8 億美元成長到 2031 年的 376.3 億美元，複合年成長率為 5.57%。

這些專用儀器採用3D座標系統，能夠精確地辨識和治療腦和脊髓內的目標區域。該領域的發展主要受神經系統疾病和中樞神經系統惡性腫瘤發病率不斷上升的推動，這些疾病和腫瘤都需要精準的醫療干預。此外，人口老化和微創手術的普及也加速了這項需求。根據美國癌症協會預測，到2025年，美國預計將新增24,820例腦部或脊髓惡性腫瘤病例，這凸顯了臨床上對這些先進介入工具日益成長的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 271.8億美元
市場規模：2031年 376.3億美元
複合年成長率：2026-2031年 5.57%
成長最快的細分市場 PBRT
最大的市場 北美洲

儘管市場前景廣闊，但大規模部署和維修成本構成了重大障礙。這些高額資金需求往往限制了預算有限的中小型醫療機構和發展中地區的採用。因此，這些經濟障礙，加上缺乏能夠管理複雜機制的專業人員，持續阻礙市場的擴張潛力。

市場促進因素

神經系統疾病發生率的不斷上升是全球立體定位手術器材市場的主要促進因素。這是因為醫療專業人員越來越依賴這些高精度工具來治療帕金森氏症和癲癇等複雜疾病。人們對精準、非侵入性的治療方法的需求日益成長，而治療方法需要精確的導航和定位能力，以應對日益嚴重的腦功能障礙和中樞神經系統病變帶來的負擔。例如，阿茲海默症協會在《2025年阿茲海默症現狀及展望》報告中指出，大約有720萬65歲及以上的美國人將患有老年失智症失智症，這凸顯了開發先進神經外科解決方案以支持研究和功能性治療的緊迫性。

同時，機器人輔助手術系統的整合正在推動市場發展，這些系統能夠提高手術精度並縮短手術時間。這些技術使外科醫生能夠利用符合人體工學的設計和自動導航系統進行精細的立體定位手術操作，擴大了可治療的適應症範圍。這項技術進步在主要產業參與者的財務表現中得到了清晰的體現。例如，Globus Medical 在其 2025 年第三季財報中宣布，其營收年增 22.9%，這主要得益於其在手術機器人和脊椎解決方案領域不斷成長的市場佔有率。此外，根據 Elekta 的 2025 年報告，全球接受 Leksell 伽瑪刀放射放射線手術治療的患者人數已超過 200 萬，這表明這些成熟平台具有持續的臨床價值，並表明立體定向治療模式正在全球範圍內得到廣泛應用。

市場挑戰

全球立體定位手術系統市場成長的主要障礙在於安裝和持續維護所需的大量資金投入。高精度神經外科系統需要大量的初始投資，這通常限制了其應用範圍，使其僅限於資金雄厚的大型醫療中心。這種成本障礙造成了市場滲透率的巨大差異，小規模醫院和醫療機構缺乏部署這些先進平台的預算。因此，製造商在將業務拓展到頂級醫療機構以外的領域時面臨挑戰，這直接阻礙了整體市場的成長。

此外，醫療產業日益收緊的財務環境加劇了這些財務限制。醫院越來越重視流動性而非資本投資，延後購買高價值介入設備的決策。這一趨勢也反映在近期醫療機構資本支出意願的產業數據中。根據美國醫院協會 (AHA) 預測，到 2025 年，94% 的醫療機構管理者將推遲設備升級以應對財務負擔。這種不願進行大規模投資的做法嚴重阻礙了立體定位手術系統的普及，並妨礙了市場在服務不足地區充分發揮其潛力。

市場趨勢

立體定位放射治療 (SBRT) 的應用範圍擴展至顱外，是一項變革性的轉變。臨床醫師擴大採用這種高劑量通訊協定治療肺、肝、前列腺等顱外標靶器官。與以往僅限於中樞神經系統的應用不同，這一趨勢的驅動力在於臨床證據表明，SBRT 的生存率與侵入性手術相當，並且能夠縮短患者的康復時間。長期療效數據也支持治療範圍的擴展。例如，在 2025 年 9 月題為“ASTRO 2025：早期肺癌 10 年 SBRT 療效與手術相當”的新聞稿中，德克薩斯大學 MD 安德森癌症中心報告稱，早期非小細胞肺癌患者的總體生存率在統計學上相當：SBRT 組為 69%，手術組為 66%。這些發現證實了該治療方法作為一種根治性治療方案在更廣泛的腫瘤適應症中的效用，並將推動其在神經外科以外的領域得到市場應用。

此外，將人工智慧 (AI) 整合到自適應治療計劃中，可以自動完成日常治療過程中諸如勾畫靶區輪廓和劑量計算等複雜流程，從根本上重塑臨床工作流程。這項技術能夠應對腫瘤縮小和器官移動等解剖結構變化，使團隊無需依賴靜態的治療前掃描即可即時創建最佳化計劃。這種自動化帶來的營運效益顯著，大幅縮短了個人化治療所需的時間。根據瓦里安公司於 2025 年 11 月發布的報告《瓦里安資助計畫在 2025 年美國醫學物理學家協會 (AAPM) 年會上的摘要揭示了構建穩健、高效癌症治療計畫的機會》，芝加哥大學的研究表明，該公司的人工智慧驅動型治療計畫系統 Ethos 將平均計畫時間從 132 分鐘縮短至僅 32 分鐘。透過簡化這些繁瑣的任務，人工智慧驅動的自適應解決方案提高了處理能力，使醫療機構能夠提供更穩定、更精準的放射治療。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：立體定位外科器械的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類型（伽瑪刀、直線加速器、PBRT、電腦刀）
    • 透過應用（肝臟、乳房、前列腺、肺、結腸等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美立體定位外科器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲立體定位外科器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區立體定位外科器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲立體定位外科器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲立體定位外科器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球立體定位外科器械市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Siemens AG
  • Elekta AB
  • Varian Medical Systems, Inc.
  • IBA Group Inc.
  • Accuray Incorporated
  • Koninklijke Philips NV
  • Hitachi Medical Systems
  • Huiheng Group
  • Ion Beam Applications SA
  • inomed Medizintechnik GmbH

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17080

The Global Stereotactic Surgery Devices Market is projected to expand from USD 27.18 Billion in 2025 to USD 37.63 Billion by 2031, registering a compound annual growth rate (CAGR) of 5.57%. These specialized instruments employ a three-dimensional coordinate system to precisely locate and treat targets within the brain and spine. Growth in this sector is largely fueled by the increasing prevalence of neurological disorders and central nervous system malignancies that require accurate medical interventions. Furthermore, an aging population and a distinct shift toward minimally invasive procedures are accelerating demand. According to the American Cancer Society, an estimated 24,820 malignant tumors of the brain or spinal cord are expected to be diagnosed in the United States in 2025, underscoring the escalating clinical necessity for these advanced interventional tools.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 27.18 Billion
Market Size 2031USD 37.63 Billion
CAGR 2026-20315.57%
Fastest Growing SegmentPBRT
Largest MarketNorth America

Despite these growth prospects, the market faces significant hurdles related to the substantial acquisition and maintenance costs of these systems. Such high financial requirements often restrict adoption in smaller healthcare facilities and developing regions operating under constrained budgets. Consequently, these economic barriers, combined with a scarcity of specialized professionals trained to manage these complex mechanisms, continue to impede the scalability of the market.

Market Driver

The increasing incidence of neurological disorders serves as a major driver for the Global Stereotactic Surgery Devices Market, as medical professionals rely more heavily on these high-precision tools to manage complex conditions like Parkinson's disease and epilepsy. There is an intensifying demand for accurate, non-invasive interventions to tackle the rising burden of functional brain disorders and central nervous system pathologies, which requires sophisticated navigation and localization capabilities. For example, the Alzheimer's Association noted in its '2025 Alzheimer's Disease Facts and Figures' report that approximately 7.2 million Americans aged 65 and older are living with Alzheimer's dementia, highlighting the urgent need for advanced neurosurgical solutions to support research and functional treatments.

Concurrently, the market is bolstered by the integration of robotic-assisted surgical systems, which improve procedural accuracy and decrease operative times. These technologies enable surgeons to execute delicate stereotactic maneuvers with better ergonomics and automated navigation, thereby broadening the range of treatable indications. This technological evolution is evident in the financial results of major industry players; for instance, Globus Medical announced a 22.9% year-over-year revenue increase in its 'Third Quarter 2025 Financial Results,' attributed largely to its growing presence in surgical robotics and spine solutions. Moreover, the widespread global adoption of stereotactic modalities is demonstrated by Elekta's 2025 report, which indicates that over two million patients worldwide have been treated using Leksell Gamma Knife radiosurgery, proving the enduring clinical value of these established platforms.

Market Challenge

The main obstacle hindering the growth of the Global Stereotactic Surgery Devices Market is the significant capital expenditure necessary for both acquisition and ongoing maintenance. High-precision neurosurgical systems require a substantial upfront investment, generally limiting their procurement to large, well-funded medical centers. This cost barrier creates a noticeable disparity in market penetration, as smaller hospitals and healthcare facilities in developing regions frequently lack the budgetary capacity to incorporate these advanced platforms. As a result, manufacturers encounter challenges in scaling their operations outside of tier-one institutions, which directly stifles broader market expansion.

Moreover, these financial limitations are intensified by a tightening fiscal climate within the healthcare industry. Hospitals are increasingly favoring operational liquidity over capital improvements, resulting in delayed purchasing decisions for high-value interventional tools. This trend is reflected in recent industry data regarding provider sentiment toward capital expenditures; according to the American Hospital Association, 94% of healthcare administrators in 2025 expect to postpone equipment upgrades to manage financial strain. This reluctance to commit to large-scale investments significantly obstructs the adoption rate of stereotactic systems, preventing the market from achieving its full potential in underserved areas.

Market Trends

The expansion of Stereotactic Body Radiation Therapy (SBRT) into non-cranial applications marks a transformative shift, with clinicians increasingly applying these high-dose protocols to treat extracranial targets such as the lung, liver, and prostate. Distinct from traditional applications restricted to the central nervous system, this trend is propelled by clinical evidence showing that SBRT delivers survival outcomes comparable to invasive resection while reducing patient recovery time. Long-term efficacy data supports this broadened therapeutic scope; for example, The University of Texas MD Anderson Cancer Center reported in a September 2025 press release titled 'ASTRO 2025: At 10 years, SBRT comparable to surgery for early-stage lung cancer' that overall survival rates for early-stage non-small cell lung cancer patients were 69% for the SBRT cohort, statistically similar to the 66% observed in the surgery cohort. These findings confirm the modality's utility as a definitive curative option for a wider range of oncology indications, driving market adoption beyond neurosurgical departments.

Additionally, the integration of Artificial Intelligence (AI) for adaptive treatment planning is fundamentally restructuring clinical workflows by automating the intricate processes of contouring and dose calculation during daily sessions. This technology resolves the issue of anatomical variations, such as tumor shrinkage or organ motion, by enabling teams to create optimized plans in real-time rather than depending on static pre-treatment scans. The operational benefit of this automation is significant, as it drastically cuts the time needed for personalized interventions. According to a November 2025 report by Varian titled 'Varian-funded abstracts at AAPM 2025 reveal opportunities to build resilient, high-performing cancer care programs,' a study at the University of Chicago showed that the company's AI-driven Ethos treatment planning system lowered average planning time from 135 minutes to just 32 minutes. By streamlining these labor-intensive tasks, AI-enabled adaptive solutions improve throughput and allow facilities to deliver hyper-precise radiation with greater consistency.

Key Market Players

  • Siemens AG
  • Elekta AB
  • Varian Medical Systems, Inc.
  • IBA Group Inc.
  • Accuray Incorporated
  • Koninklijke Philips N.V.
  • Hitachi Medical Systems
  • Huiheng Group
  • Ion Beam Applications S.A.
  • inomed Medizintechnik GmbH

Report Scope

In this report, the Global Stereotactic Surgery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Stereotactic Surgery Devices Market, By Product Type

  • Gamma Knife
  • LINAC
  • PBRT
  • CyberKnife

Stereotactic Surgery Devices Market, By Application

  • Liver
  • Breast
  • Prostate
  • Lung
  • Colon
  • Others

Stereotactic Surgery Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Stereotactic Surgery Devices Market.

Available Customizations:

Global Stereotactic Surgery Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Stereotactic Surgery Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Gamma Knife, LINAC, PBRT, CyberKnife)
    • 5.2.2. By Application (Liver, Breast, Prostate, Lung, Colon, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Stereotactic Surgery Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Stereotactic Surgery Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Stereotactic Surgery Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Stereotactic Surgery Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application

7. Europe Stereotactic Surgery Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Stereotactic Surgery Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Stereotactic Surgery Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Stereotactic Surgery Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Stereotactic Surgery Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Stereotactic Surgery Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Stereotactic Surgery Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Stereotactic Surgery Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Stereotactic Surgery Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Stereotactic Surgery Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Stereotactic Surgery Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Stereotactic Surgery Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Stereotactic Surgery Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Stereotactic Surgery Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Stereotactic Surgery Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Stereotactic Surgery Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application

10. South America Stereotactic Surgery Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Stereotactic Surgery Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Stereotactic Surgery Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Stereotactic Surgery Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Stereotactic Surgery Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Siemens AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Elekta AB
  • 15.3. Varian Medical Systems, Inc.
  • 15.4. IBA Group Inc.
  • 15.5. Accuray Incorporated
  • 15.6. Koninklijke Philips N.V.
  • 15.7. Hitachi Medical Systems
  • 15.8. Huiheng Group
  • 15.9. Ion Beam Applications S.A.
  • 15.10. inomed Medizintechnik GmbH

16. Strategic Recommendations

17. About Us & Disclaimer